Surgalign Holdings (Surgalign Holdings) Risk Assessment

View and export this data going back to 2000. Start your Free Trial

What is Surgalign Holdings Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Surgalign Holdings is: No Data: Cannot be evaluated.

Competitive Comparison of Surgalign Holdings's Risk Assessment

For the Medical Devices subindustry, Surgalign Holdings's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgalign Holdings's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgalign Holdings's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Surgalign Holdings's Risk Assessment falls into.

Surgalign Holdings (OTCPK:SRGAQ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Surgalign Holdings Risk Assessment Related Terms

Thank you for viewing the detailed overview of Surgalign Holdings's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgalign Holdings (Surgalign Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgalign Holdings Inc (OTCPK:SRGAQ) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

520 Lake Cook Road, Suite 315, Deerfield, IL, USA, 60015

Website

https://www.surgalign.com

Surgalign Holdings Inc is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver the Best surgical outcomes and improve patient's lives. It markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. The U.S. market accounts for the vast majority of revenue. It has commercial and design centers in San Diego, California, and Wurmlingen, Germany.

Executives

Elizabeth A. Lapuma	director	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Jill Kathleen Frizzley	director	P.O. BOX 1541, ONE BLUE HILL PLAZA, PEARL RIVER NY 10965
Paolo Amoruso	officer: Chief Legal Officer	C/O HYPERDYNAMICS CORPORATION, 12012 WICKCHESTER LANE, SUITE 475, HOUSTON TX 77079
David Lyle	officer: Chief Financial Officer	6290 SEQUENCE DRIVE, SAN DIEGO CA 92121
Marc E. Mackey	officer: EVP, Digital Surgery	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Terry M. Rich	officer: President, Global Spine	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
William Scott Durall	officer: Chief Commercial Officer	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Christopher Thunander	officer: Chief Accounting Officer	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Thomas Mceachin	director	11621 RESEARCH CIRCLE, ALACHUA FL 32615
Nicholas J Valeriani	director	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Sheryl L Conley	director	C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN PA 19355
Enrico Sangiorgio	officer: EVP, International	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Stuart F. Simpson	director	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Pawel Lewicki	director	296 WOODWARD BLVD., TULSA OK 74114
Jeffrey C Lightcap	director	152 W 57TH STREET 43RD FLOOR, NEW YORK NY 10019